Point72 Hong Kong LTD Accelerate Diagnostics, Inc Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $4,547 - $7,423	-1,065 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $5,655 - $8,786	1,065 New	1,065 $6,000
Q1 2021 May 17, 2021	SELL	$7.99 - $15.0 $10,019 - $18,810	-1,254 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $4,871 - $8,096	692 Added 123.13%	1,254 $10,000
Q3 2020 Nov 16, 2020	SELL	$9.98 - $18.04 $189 - $342	-19 Reduced 3.27%	562 $6,000
Q2 2020 Aug 14, 2020	BUY	$7.49 - $15.16 $2,951 - $5,973	394 Added 210.7%	581 $9,000
Q1 2020 May 15, 2020	BUY	$4.62 - $18.74 $863 - $3,504	187 New	187 $2,000
Q2 2019 Aug 14, 2019	SELL	$17.79 - $22.88 $676 - $869	-38 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.76 - $22.15 $446 - $841	38 New	38 $1,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.